Molbio Diagnostics, a Goa-based POC diagnostics company, filed its DRHP to raise Rs 200 crore via fresh issue and 1.25 crore shares through OFS. Its patented ‘Truenat’ PCR platform enables rapid decentralized testing. FY25 revenue stood at Rs 1,020 crore, PAT Rs 138.5 crore. Promoters include Sriram family and Exxora Trading.
US stock market crash fears ease even as Middle East war rages on
Options traders’ fears of a U.S. stock market crash have significantly receded, with key indices like the Nations TailDex and Cboe Skew returning to pre-Iran